Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study.

Autor: Wong, Carlos King Ho1,2,3 (AUTHOR), Lau, Kristy Tsz Kwan2 (AUTHOR), Tang, Eric Ho Man1 (AUTHOR), Lee, Chi Ho4 (AUTHOR), Lee, Carmen Yu Yan4 (AUTHOR), Woo, Yu Cho4 (AUTHOR), Au, Ivan Chi Ho2 (AUTHOR), Tan, Kathryn Choon Beng4 (AUTHOR), Lui, David Tak Wai4 (AUTHOR) dtwlui@hku.hk
Zdroj: Cardiovascular Diabetology. 6/3/2022, Vol. 21 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje